|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/50 | |
| G01N 33/574 | |||
| A61K 31/00 |
| (11) | Patento numeris | 2533047 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12182790.1 |
| Europos patento paraiškos padavimo data | 2008-09-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-12-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-05-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 0718167 | 2007-09-18 | GB |
| (72) |
Slettenaar, Violet, GB
Wilson, Julia, GB
Wang, Yaohe, GB
Schioppa, Tiziana, GB
Balkwill, Frances, GB
|
| (73) |
Cancer Research Technology Limited,
Angel Building 407 St John Street, London EC1V 4AD,
GB
|
| (54) | CCR4 AS THERAPEUTIC TARGET FOR CANCER |
| CCR4 AS THERAPEUTIC TARGET FOR CANCER |